SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (5570)1/28/2002 6:08:36 PM
From: michael_f_murphy  Respond to of 52153
 
Morgan Stanley Biotech Index is equal, not capitalization, weighted.

morganstanley.com



To: quidditch who wrote (5570)1/28/2002 7:42:12 PM
From: tom pope  Respond to of 52153
 
Are you referring to the NBI (Nasdaq BioTech) index, which was modified last year? It is, however capitalization weighted.

The Nasdaq Biotechnology Index contains companies primarily engaged in using biomedical research for the discovery or development of novel treatments or cures for human disease which also meet other eligibility criteria. The Nasdaq Biotechnology Index is calculated under a modified capitalization-weighted methodology.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News